Bonamour, Inc. (fka BONI)

[Madkins]

Bonamour, Inc., (OTCQB: BONI) announced today that BuyIns.net has
initiated coverage on the Company’s stock. The Buyins.net report states
that the total aggregate number of shares shorted since June 2012 is
approximately 1.68 million shares. Approximately 16.84% of daily trading
volume is short selling. The SqueezeTrigger price for all BONI shares
shorted is $0.24. A short squeeze is expected to begin when shares of
BONI close above the $0.24 SqueezeTrigger price. According to his web
site, BuyIns.Net founder, Tom Ronk, entered into a business partnership
with former SEC Chairman, Harvey Pitt. They spearheaded the passage of
Regulation SHO that, if followed, helps safeguard public companies from
these sorts of short selling issues.

Click here to view the full report: http://www.buyins.com/reports/boni2-25-14.pdf




Click here for SqueezeTrigger: http://www.buyins.com/images2/bonistr2-25-14.jpg
About Bonamour, Inc.:

Bonamour, Inc. is a Dallas-based developer and brand owner of a high end
line of anti-aging skin care products often referred to as
cosmeceuticals. The Company's products are marketed and sold through its
affiliate and sales arm, Bonamour International, LLC. Bonamour
International is focused on building a network marketing and direct
sales/distribution organization for the Bonamour brand in Asia. The
Company's target markets are comprised of nearly three billion people,
many of whom are experiencing rapidly rising personal incomes and a
strong affinity for U.S. made luxury goods. For additional information
log on to www.bonamour.com.

Safe Harbor

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended that
represent the company's current expectations and beliefs. All statements
other than statements of historical fact are "forward-looking
statements" for purposes of federal and state securities laws and
include, but are not limited to, statements of management's expectations
regarding the company's performance, initiatives, goals, strategies and
new product introductions; statements of projections regarding
international sales targets and goals in Asia including Mainland China;
statements of belief; and statements of assumptions underlying any of
the foregoing. In some cases, you can identify these statements by
forward-looking words such as "believe," "expect," "project,"
"anticipate," "estimate," "intend," "plan," "targets," "likely," "will,"
"would," "could," "may," "might," the negative of these words and other
similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed
herein. These risks and uncertainties include, but are not limited to,
the following:

any changes in operations or future financial results from those
currently anticipated;

any failure of current or planned initiatives or products to generate
interest among distributors and customers and generate sponsoring and
selling activities on a sustained basis;

risks related to accurately predicting, delivering or maintaining
sufficient quantities of products to support our planned initiatives
or launch strategies, including possible ingredient supply limitations;

risk of foreign currency fluctuations and the currency translation
impact on the company's business associated with these fluctuations;

regulatory risks associated with the company's products, which could
require the company to modify its claims or inhibit the company's
ability to import or continue selling a product in a market if it is
determined to be a medical device or if it is unable to register the
product in a timely manner under applicable regulatory requirements;

any inability to secure necessary governmental approvals or licenses
to effect any future changes or expansion;

regulatory scrutiny and investigations in target markets in Asia and
other foreign markets, that could in the future, negatively impact the
company's business, including the interruption of sales activities in
stores, loss of licenses, and the imposition of fines;

adverse publicity related to the company's business, products,
industry or any legal actions or complaints by distributors or others;
and

continued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of
associated risks set forth in the documents filed by the company with
the Securities and Exchange Commission. The forward-looking statements
set forth the company's beliefs as of the date that such information was
first provided and the company assumes no duty to update the
forward-looking statements contained in this release to reflect any
change except as required by law.

http://www.otcdynamics.com/buyins-net-initiates-coverage-on-bonamour-inc-detailing-short-positions-and-potential-squeeze-trigger-price